导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.63% | 756/1050 |
| 近一周 | -1.53% | 571/1104 |
| 近一月 | -0.07% | 132/1103 |
| 近一季 | -4.92% | 467/1092 |
| 近半年 | -6.44% | 673/1070 |
| 近一年 | -6.82% | 697/1018 |
| 近两年 | 41.87% | 577/926 |
| 近三年 | 9.30% | 601/834 |
| 成立以来 | 120.06% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.94% 857/1070 |
9.54% 551/1101 |
- - |
- - |
| 2025 | 21.99% 630/1065 |
-1.94% 908/1014 |
3.09% 429/1038 |
22.67% 518/1050 |
-1.63% 539/1065 |
| 2024 | 0.25% 574/1011 |
-7.60% 674/960 |
-7.22% 755/983 |
17.44% 118/991 |
-0.42% 345/1011 |
| 2023 | -7.06% 255/952 |
18.60% 36/880 |
-3.71% 429/895 |
-11.75% 668/915 |
-7.79% 745/952 |
| 2022 | -16.07% 202/867 |
-8.23% 72/773 |
-4.02% 751/806 |
-7.63% 125/845 |
3.16% 273/867 |
| 2021 | -2.94% 398/740 |
-3.71% 289/580 |
-0.53% 552/659 |
-4.27% 322/704 |
5.86% 190/740 |
| 2020 | 22.54% 377/554 |
- 157/419 |
14.84% 356/466 |
3.70% 377/517 |
2.90% 470/554 |
| 2019 | 70.86% 40/410 |
53.63% 2/1146 |
-6.14% 785/1228 |
4.81% 203/390 |
13.05% 93/410 |
| 2018 | -18.75% 56/349 |
- - |
-2.77% 137/990 |
-11.65% 850/1000 |
-7.05% 106/1080 |
| 2017 | 23.46% 72/285 |
- - |
- - |
- - |
- - |
| 2016 | 8.05% 8/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 前海开源再融资股票 VS. 东吴新产业精选股票A(580008) |